Global Equine Influenza Vaccine Market 2018 - Industry Research Report

Request for a SAMPLE REPORT

Fill up your details below and get the sample report for FREE
 

Global Equine Influenza Vaccine Market 2018 - Industry Research Report

 Published Date : Oct-2018   |    Format :PDF |    Number of Pages : 115   |    Publisher : Extense Research

In 2017, the global Equine Influenza Vaccine market size was  million US$ and is forecast to  million US in 2025, growing at a CAGR of  from 2018. The objectives of this study are to define, segment, and project the size of the Equine Influenza Vaccine market based on company, product type, application and key regions.

This report studies the global market size of Equine Influenza Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Equine Influenza Vaccine in these regions.
This research report categorizes the global Equine Influenza Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

The various contributors involved in the value chain of Equine Influenza Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Equine Influenza Vaccine include
    Zoetis
    Merck Animal Health
    Boehringer Ingelheim Vetmedica

Market Size Split by Type
    Liquid
    Powder
Market Size Split by Application
    Home
    Pet Clinic
    Other

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Equine Influenza Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Equine Influenza Vaccine market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Equine Influenza Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Equine Influenza Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Equine Influenza Vaccine submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Equine Influenza Vaccine are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Equine Influenza Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Equine Influenza Vaccine Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Equine Influenza Vaccine Market Size Growth Rate by Type
        1.4.2 Liquid
        1.4.3 Powder
    1.5 Market by Application
        1.5.1 Global Equine Influenza Vaccine Market Size Growth Rate by Application
        1.5.2 Home
        1.5.3 Pet Clinic
        1.5.4 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Equine Influenza Vaccine Market Size
        2.1.1 Global Equine Influenza Vaccine Revenue 2016-2025
        2.1.2 Global Equine Influenza Vaccine Sales 2016-2025
    2.2 Equine Influenza Vaccine Growth Rate by Regions
        2.2.1 Global Equine Influenza Vaccine Sales by Regions
        2.2.2 Global Equine Influenza Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Equine Influenza Vaccine Sales by Manufacturers
        3.1.1 Equine Influenza Vaccine Sales by Manufacturers
        3.1.2 Equine Influenza Vaccine Sales Market Share by Manufacturers
        3.1.3 Global Equine Influenza Vaccine Market Concentration Ratio (CR5 and HHI)
    3.2 Equine Influenza Vaccine Revenue by Manufacturers
        3.2.1 Equine Influenza Vaccine Revenue by Manufacturers (2016-2018)
        3.2.2 Equine Influenza Vaccine Revenue Share by Manufacturers (2016-2018)
    3.3 Equine Influenza Vaccine Price by Manufacturers
    3.4 Equine Influenza Vaccine Manufacturing Base Distribution, Product Types
        3.4.1 Equine Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Equine Influenza Vaccine Product Category
        3.4.3 Date of International Manufacturers Enter into Equine Influenza Vaccine  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Equine Influenza Vaccine Sales by Type
    4.2 Global Equine Influenza Vaccine Revenue by Type
    4.3 Equine Influenza Vaccine Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Equine Influenza Vaccine Breakdown Data by Application

6 North America
    6.1 North America Equine Influenza Vaccine by Countries
        6.1.1 North America Equine Influenza Vaccine Sales by Countries
        6.1.2 North America Equine Influenza Vaccine Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Equine Influenza Vaccine by Type
    6.3 North America Equine Influenza Vaccine by Application
    6.4 North America Equine Influenza Vaccine by Company

7 Europe
    7.1 Europe Equine Influenza Vaccine by Countries
        7.1.1 Europe Equine Influenza Vaccine Sales by Countries
        7.1.2 Europe Equine Influenza Vaccine Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Equine Influenza Vaccine by Type
    7.3 Europe Equine Influenza Vaccine by Application
    7.4 Europe Equine Influenza Vaccine by Company

8 Asia Pacific
    8.1 Asia Pacific Equine Influenza Vaccine by Countries
        8.1.1 Asia Pacific Equine Influenza Vaccine Sales by Countries
        8.1.2 Asia Pacific Equine Influenza Vaccine Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Equine Influenza Vaccine by Type
    8.3 Asia Pacific Equine Influenza Vaccine by Application
    8.4 Asia Pacific Equine Influenza Vaccine by Company

9 Central & South America
    9.1 Central & South America Equine Influenza Vaccine by Countries
        9.1.1 Central & South America Equine Influenza Vaccine Sales by Countries
        9.1.2 Central & South America Equine Influenza Vaccine Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Equine Influenza Vaccine by Type
    9.3 Central & South America Equine Influenza Vaccine by Application
    9.4 Central & South America Equine Influenza Vaccine by Company

10 Middle East and Africa
    10.1 Middle East and Africa Equine Influenza Vaccine by Countries
        10.1.1 Middle East and Africa Equine Influenza Vaccine Sales by Countries
        10.1.2 Middle East and Africa Equine Influenza Vaccine Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Equine Influenza Vaccine by Type
    10.3 Middle East and Africa Equine Influenza Vaccine by Application
    10.4 Middle East and Africa Equine Influenza Vaccine by Company

11 Company Profiles
    11.1 Zoetis
        11.1.1 Zoetis Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Equine Influenza Vaccine
        11.1.4 Equine Influenza Vaccine Product Description
        11.1.5 Recent Development
    11.2 Merck Animal Health
        11.2.1 Merck Animal Health Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Equine Influenza Vaccine
        11.2.4 Equine Influenza Vaccine Product Description
        11.2.5 Recent Development
    11.3 Boehringer Ingelheim Vetmedica
        11.3.1 Boehringer Ingelheim Vetmedica Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Equine Influenza Vaccine
        11.3.4 Equine Influenza Vaccine Product Description
        11.3.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Equine Influenza Vaccine Raw Material
        13.1.2 Equine Influenza Vaccine Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Equine Influenza Vaccine
    Figure Global Equine Influenza Vaccine Production (K Doses) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Equine Influenza Vaccine Production Market Share by Types (Product Category) in 2017
    Figure Liquid Product Picture
    Table Major Manufacturers of Liquid
    Figure Powder Product Picture
    Table Major Manufacturers of Powder
    Table Global Equine Influenza Vaccine Market Size Growth Rate by Application 2018-2025 (K Doses)
    Figure Home
    Figure Pet Clinic
    Figure Other
    Figure Equine Influenza Vaccine Report Years Considered
    Figure Global Equine Influenza Vaccine Market Size 2016-2025 (Million US$)
    Figure Global Equine Influenza Vaccine Sales 2016-2025 (K Doses)
    Table Global Equine Influenza Vaccine Market Size by Regions 2016-2025 (K Doses) & (Million US$)
    Table Global Equine Influenza Vaccine Sales by Regions 2016-2025 (K Doses)
    Table Global Equine Influenza Vaccine Sales Market Share by Regions 2016-2025
    Figure Global Equine Influenza Vaccine Sales Market Share by Regions 2016-2025
    Figure 2017 Global Equine Influenza Vaccine Sales Market Share by Regions
    Table Global Equine Influenza Vaccine Revenue by Regions 2016-2025 (Million US$)
    Table Global Equine Influenza Vaccine Revenue Market Share by Regions 2016-2025
    Figure Global Equine Influenza Vaccine Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Equine Influenza Vaccine Revenue Market Share by Regions
    Table Global Equine Influenza Vaccine Sales by Manufacturers (2016-2018) (K Doses)
    Table Global Equine Influenza Vaccine Sales Share by Manufacturers (2016-2018)
    Figure Global Equine Influenza Vaccine Sales Share by Manufacturers in 2017
    Table Equine Influenza Vaccine Revenue by Manufacturers (2016-2018) (Million US$)
    Table Equine Influenza Vaccine Revenue Share by Manufacturers (2016-2018)
    Figure Equine Influenza Vaccine Value Share by Manufacturers in 2017
    Table Global Equine Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Equine Influenza Vaccine Price (2016-2018) (USD/Dose)
    Table Equine Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Equine Influenza Vaccine Product Category
    Table Date of International Manufacturers Enter into Equine Influenza Vaccine Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Equine Influenza Vaccine Sales by Type (2016-2025) (K Doses)
    Table Global Equine Influenza Vaccine Sales Share by Type (2016-2025)
    Figure Global Equine Influenza Vaccine Sales Market Share by Type (2016-2025)
    Figure Global Equine Influenza Vaccine Sales Market Share by Type in 2017
    Table Global Equine Influenza Vaccine Revenue by Type (2016-2025) (Million US$)
    Table Global Equine Influenza Vaccine Revenue Share by Type (2016-2025)
    Figure Global Equine Influenza Vaccine Revenue Market Share by Type (2016-2025)
    Figure Global Equine Influenza Vaccine Revenue Market Share by Type in 2017
    Table Equine Influenza Vaccine Price by Type 2013-2018 (USD/Dose)
    Table Global Equine Influenza Vaccine Sales by Application (2016-2025) (K Doses)
    Table Global Equine Influenza Vaccine Sales Share by Application (2016-2025)
    Figure Global Sales Equine Influenza Vaccine Market Share by Application (2016-2025)
    Figure Global Sales Equine Influenza Vaccine Market Share by Application (2016-2025)
    Figure North America Equine Influenza Vaccine Sales Growth Rate 2016-2025 (K Doses)
    Figure North America Equine Influenza Vaccine Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Equine Influenza Vaccine Sales by Countries (2016-2025) (K Doses)
    Table North America Equine Influenza Vaccine Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Equine Influenza Vaccine Sales Market Share by Countries
    Table North America Equine Influenza Vaccine Revenue by Countries (2016-2025) (Million US$)
    Table North America Equine Influenza Vaccine Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Equine Influenza Vaccine Revenue Market Share by Countries
    Figure United States Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure United States Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Canada Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Mexico Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Equine Influenza Vaccine Sales by Type (2016-2025) (K Doses)
    Table North America Equine Influenza Vaccine Sales Market Share by Type (2016-2025)
    Figure 2017 North America Equine Influenza Vaccine Market Share by Type
    Table North America Equine Influenza Vaccine Sales by Application (2016-2025) (K Doses)
    Table North America Equine Influenza Vaccine Sales Market Share by Application (2016-2025)
    Figure 2017 North America Equine Influenza Vaccine Market Share by Application
    Table North America Equine Influenza Vaccine Sales by Company (2016-2018) (K Doses)
    Table North America Equine Influenza Vaccine Sales Market Share by Company (2016-2018)
    Figure North America Equine Influenza Vaccine Sales Market Share by Company in 2017
    Figure Europe Equine Influenza Vaccine Sales Growth Rate 2016-2025 (K Doses)
    Figure Europe Equine Influenza Vaccine Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Equine Influenza Vaccine Sales by Countries (2016-2025) (K Doses)
    Table Europe Equine Influenza Vaccine Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Equine Influenza Vaccine Sales Market Share by Countries
    Table Europe Equine Influenza Vaccine Revenue by Countries (2016-2025) (Million US$)
    Table Europe Equine Influenza Vaccine Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Equine Influenza Vaccine Revenue Market Share by Countries
    Figure Germany Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Germany Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (K Doses)
    Figure France Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure France Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (K Doses)
    Figure UK Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure UK Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Italy Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Russia Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Equine Influenza Vaccine Sales by Type (2016-2025) (K Doses)
    Table Europe Equine Influenza Vaccine Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Equine Influenza Vaccine Market Share by Type
    Table Europe Equine Influenza Vaccine Sales by Application (2016-2025) (K Doses)
    Table Europe Equine Influenza Vaccine Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Equine Influenza Vaccine Market Share by Application
    Table Europe Equine Influenza Vaccine Sales by Company (2016-2018) (K Doses)
    Table Europe Equine Influenza Vaccine Sales Market Share by Company (2016-2018)
    Figure Europe Equine Influenza Vaccine Sales Market Share by Company in 2017
    Figure Asia Pacific Equine Influenza Vaccine Sales Growth Rate 2016-2025 (K Doses)
    Figure Asia Pacific Equine Influenza Vaccine Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Equine Influenza Vaccine Sales by Countries (2016-2025) (K Doses)
    Table Asia Pacific Equine Influenza Vaccine Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Equine Influenza Vaccine Sales Market Share by Countries
    Table Asia Pacific Equine Influenza Vaccine Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Equine Influenza Vaccine Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Equine Influenza Vaccine Revenue Market Share by Countries
    Figure China Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure China Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Japan Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Korea Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure India Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Australia Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Indonesia Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Malaysia Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Philippines Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Thailand Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Vietnam Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Singapore Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Equine Influenza Vaccine Sales by Type (2016-2025) (K Doses)
    Table Asia Pacific Equine Influenza Vaccine Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Equine Influenza Vaccine Market Share by Type
    Table Asia Pacific Equine Influenza Vaccine Sales by Application (2016-2025) (K Doses)
    Table Asia Pacific Equine Influenza Vaccine Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Equine Influenza Vaccine Market Share by Application
    Table Asia Pacific Equine Influenza Vaccine Sales by Company (2016-2018) (K Doses)
    Table Asia Pacific Equine Influenza Vaccine Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Equine Influenza Vaccine Sales Market Share by Company in 2017
    Figure Central & South America Equine Influenza Vaccine Sales Growth Rate 2016-2025 (K Doses)
    Figure Central & South America Equine Influenza Vaccine Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Equine Influenza Vaccine Sales by Countries (2016-2025) (K Doses)
    Table Central & South America Equine Influenza Vaccine Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Equine Influenza Vaccine Sales Market Share by Countries
    Table Central & South America Equine Influenza Vaccine Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Equine Influenza Vaccine Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Equine Influenza Vaccine Revenue Market Share by Countries
    Figure Brazil Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Brazil Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Argentina Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Equine Influenza Vaccine Sales by Type (2016-2025) (K Doses)
    Table Central & South America Equine Influenza Vaccine Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Equine Influenza Vaccine Market Share by Type
    Table Central & South America Equine Influenza Vaccine Sales by Application (2016-2025) (K Doses)
    Table Central & South America Equine Influenza Vaccine Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Equine Influenza Vaccine Market Share by Application
    Table Central & South America Equine Influenza Vaccine Sales by Company (2016-2018) (K Doses)
    Table Central & South America Equine Influenza Vaccine Sales Market Share by Company (2016-2018)
    Figure Central & South America Equine Influenza Vaccine Sales Market Share by Company in 2017
    Figure Middle East and Africa Equine Influenza Vaccine Sales Growth Rate 2016-2025 (K Doses)
    Figure Middle East and Africa Equine Influenza Vaccine Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Equine Influenza Vaccine Sales by Countries (2016-2025) (K Doses)
    Table Middle East and Africa Equine Influenza Vaccine Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Equine Influenza Vaccine Sales Market Share by Countries
    Table Middle East and Africa Equine Influenza Vaccine Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Equine Influenza Vaccine Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Equine Influenza Vaccine Revenue Market Share by Countries
    Figure GCC Countries Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure GCC Countries Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Turkey Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure Egypt Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Equine Influenza Vaccine Sales Growth Rate (2016-2025) (K Doses)
    Figure South Africa Equine Influenza Vaccine Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Equine Influenza Vaccine Sales by Type (2016-2025) (K Doses)
    Table Middle East and Africa Equine Influenza Vaccine Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Equine Influenza Vaccine Market Share by Type
    Table Middle East and Africa Equine Influenza Vaccine Sales by Application (2016-2025) (K Doses)
    Table Middle East and Africa Equine Influenza Vaccine Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Equine Influenza Vaccine Market Share by Application
    Table Middle East and Africa Equine Influenza Vaccine Sales by Company (2016-2018) (K Doses)
    Table Middle East and Africa Equine Influenza Vaccine Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Equine Influenza Vaccine Sales Market Share by Company in 2017
    Table Zoetis Company Details
    Table Zoetis Equine Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
    Table Zoetis Recent Development
    Table Merck Animal Health Company Details
    Table Merck Animal Health Equine Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
    Table Merck Animal Health Recent Development
    Table Boehringer Ingelheim Vetmedica Company Details
    Table Boehringer Ingelheim Vetmedica Equine Influenza Vaccine Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2018)
    Table Boehringer Ingelheim Vetmedica Recent Development
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Equine Influenza Vaccine Value Chain
    Table Typical Suppliers of Key Equine Influenza Vaccine Raw Material
    Table Equine Influenza Vaccine Customers List
    Table Equine Influenza Vaccine Sales Channels
    Table Equine Influenza Vaccine Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

 Select a Format



 Buy Now

24/7 Customer Support

Have questions?

Direct
+1-386-310-3803
Toll Free
+1-855-465-4651
sales@extentresearch.com